Fulcrum Capital LLC Sells 5,127 Shares of Lam Research Corporation $LRCX

Key Points

• Fulcrum Capital reduced its Lam Research stake by 6.7%, selling 5,127 shares during the second quarter while retaining 71,266 shares valued at approximately $30.9 million. Institutional investors and hedge funds collectively own 84.61% of the company.
• Lam Research exceeded quarterly expectations, reporting $1.82 in EPS and $6.72 billion in revenue; revenue increased 30% year over year. The company issued Q1 2027 EPS guidance of $2.00–$2.30.
• Wall Street remains bullish, with 27 analysts rating the stock Strong Buy or Buy and an average target price of $358.47. However, insiders sold 80,441 shares worth $27.6 million during the latest quarter.

Fulcrum Capital LLC trimmed its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 6.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 71,266 shares of the semiconductor company's stock after selling 5,127 shares during the quarter. Lam Research makes up 6.3% of Fulcrum Capital LLC's holdings, making the stock its 2nd largest position. Fulcrum Capital LLC's holdings in Lam Research were worth $30,882,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the company. Norges Bank acquired a new position in Lam Research during the fourth quarter worth approximately $3,645,427,000. Price T Rowe Associates Inc. MD lifted its position in shares of Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock valued at $2,344,347,000 after buying an additional 10,666,540 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Lam Research by 57.0% during the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company's stock worth $1,730,724,000 after acquiring an additional 3,671,073 shares during the period. Corient Private Wealth LLC boosted its stake in shares of Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company's stock worth $890,040,000 after acquiring an additional 3,649,553 shares during the period. Finally, J. Stern & Co. LLP increased its holdings in shares of Lam Research by 3,826.9% during the 4th quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company's stock worth $592,176,000 after acquiring an additional 3,371,283 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares in the company, valued at approximately $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 over the last quarter. 0.31% of the stock is owned by company insiders.

Lam Research Price Performance

NASDAQ:LRCX opened at $307.17 on Thursday. Lam Research Corporation has a 52 week low of $94.11 and a 52 week high of $438.50. The firm's 50-day simple moving average is $339.57 and its 200 day simple moving average is $285.35. The firm has a market cap of $384.37 billion, a price-to-earnings ratio of 53.33, a P/E/G ratio of 1.30 and a beta of 1.84. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.13. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The firm's quarterly revenue was up 30.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 9.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on LRCX shares. Stifel Nicolaus raised their price target on Lam Research from $325.00 to $425.00 and gave the company a "buy" rating in a report on Friday, July 10th. TD Cowen reiterated a "buy" rating and issued a $400.00 price objective (up from $340.00) on shares of Lam Research in a report on Thursday, July 9th. UBS Group reissued a "buy" rating and issued a $375.00 price objective (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. Needham & Company LLC restated a "buy" rating and set a $390.00 target price on shares of Lam Research in a research note on Thursday, July 30th. Finally, Citigroup reaffirmed a "buy" rating and set a $450.00 target price (up from $315.00) on shares of Lam Research in a report on Wednesday, June 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and an average target price of $358.47.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source